Shopping Cart 0
Cart Subtotal
USD 0

Sonoma Pharmaceuticals Inc (SNOA) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, among others. It offers women's healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare, among others. Sonoma develops its products based on shelf-stable microcyn technology platform. The company sells its products through OTC stores. The company operates in the Netherlands and the US. Sonoma is headquartered in Petaluma, California, the US.

Sonoma Pharmaceuticals Inc (SNOA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sonoma Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Partnerships 10

Oculus Innovative Sciences Enters into Agreement with Lipogrid 10

Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11

Equity Offering 12

Sonoma Pharma Prices Public Offering of Units 12

Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13

Oculus Innovative Sciences Completes Public Offering Of Common Stock For USD 3.5 Million 15

Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For USD 1 Million 16

Oculus Innovative Sciences Completes Private Placement Of Shares For USD 2 Million 17

Sonoma Pharmaceuticals Inc-Key Competitors 18

Sonoma Pharmaceuticals Inc-Key Employees 19

Sonoma Pharmaceuticals Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Business Unit 20

Recent Developments 22

Financial Announcements 22

Nov 08, 2018: Sonoma Pharmaceuticals reports record revenue in second quarter FY 2019 22

Aug 08, 2018: Sonoma Pharmaceuticals reports first quarter fy 2019 financial results 24

Jun 13, 2018: Sonoma Pharmaceuticals Announces Fiscal Year And Fourth Quarter 2018 Financial Results 25

Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of USD 4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% 27

Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of USD 4.3 Million 29

Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 31

Jun 05, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017 32

Feb 09, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 34

Corporate Communications 36

Sep 19, 2018: Sonoma Pharmaceuticals names Phillipe Weigerstorfer as Board Director 36

May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer 37

Jan 31, 2017: Sonoma Pharmaceuticals Appoints Marc Umscheid As Chief Strategy And Marketing Officer 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Sonoma Pharmaceuticals Inc, Medical Equipment, Key Facts, 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sonoma Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Oculus Innovative Sciences Enters into Agreement with Lipogrid 10

Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11

Sonoma Pharma Prices Public Offering of Units 12

Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13

Oculus Innovative Sciences Completes Public Offering Of Common Stock For USD 3.5 Million 15

Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For USD 1 Million 16

Oculus Innovative Sciences Completes Private Placement Of Shares For USD 2 Million 17

Sonoma Pharmaceuticals Inc, Key Competitors 18

Sonoma Pharmaceuticals Inc, Key Employees 19

Sonoma Pharmaceuticals Inc, Other Locations 20

Sonoma Pharmaceuticals Inc, Subsidiaries 20

Sonoma Pharmaceuticals Inc, Business Unit 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sonoma Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, among others. It offers women's healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare, among others. Sonoma develops its products based on shelf-stable microcyn technology platform. The company sells its products through OTC stores. The company operates in the Netherlands and the US. Sonoma is headquartered in Petaluma, California, the US.

Sonoma Pharmaceuticals Inc (SNOA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sonoma Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Partnerships 10

Oculus Innovative Sciences Enters into Agreement with Lipogrid 10

Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11

Equity Offering 12

Sonoma Pharma Prices Public Offering of Units 12

Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13

Oculus Innovative Sciences Completes Public Offering Of Common Stock For USD 3.5 Million 15

Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For USD 1 Million 16

Oculus Innovative Sciences Completes Private Placement Of Shares For USD 2 Million 17

Sonoma Pharmaceuticals Inc-Key Competitors 18

Sonoma Pharmaceuticals Inc-Key Employees 19

Sonoma Pharmaceuticals Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Business Unit 20

Recent Developments 22

Financial Announcements 22

Nov 08, 2018: Sonoma Pharmaceuticals reports record revenue in second quarter FY 2019 22

Aug 08, 2018: Sonoma Pharmaceuticals reports first quarter fy 2019 financial results 24

Jun 13, 2018: Sonoma Pharmaceuticals Announces Fiscal Year And Fourth Quarter 2018 Financial Results 25

Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of USD 4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% 27

Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of USD 4.3 Million 29

Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 31

Jun 05, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017 32

Feb 09, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 34

Corporate Communications 36

Sep 19, 2018: Sonoma Pharmaceuticals names Phillipe Weigerstorfer as Board Director 36

May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer 37

Jan 31, 2017: Sonoma Pharmaceuticals Appoints Marc Umscheid As Chief Strategy And Marketing Officer 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Sonoma Pharmaceuticals Inc, Medical Equipment, Key Facts, 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sonoma Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Oculus Innovative Sciences Enters into Agreement with Lipogrid 10

Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11

Sonoma Pharma Prices Public Offering of Units 12

Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13

Oculus Innovative Sciences Completes Public Offering Of Common Stock For USD 3.5 Million 15

Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For USD 1 Million 16

Oculus Innovative Sciences Completes Private Placement Of Shares For USD 2 Million 17

Sonoma Pharmaceuticals Inc, Key Competitors 18

Sonoma Pharmaceuticals Inc, Key Employees 19

Sonoma Pharmaceuticals Inc, Other Locations 20

Sonoma Pharmaceuticals Inc, Subsidiaries 20

Sonoma Pharmaceuticals Inc, Business Unit 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Sonoma Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat